BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Xue DD, Zhang X, Li DW, Yang YL, Liu JJ. Protective effect of liraglutide on the myocardium of type 2 diabetic rats by inhibiting polyadenosine diphosphate-ribose polymerase-1. World J Diabetes 2023; 14(2): 110-119 [PMID: 36926657 DOI: 10.4239/wjd.v14.i2.110]
URL: https://www.wjgnet.com/1948-9358/full/v14/i2/110.htm
Number Citing Articles
1
Xueqing Li, Wei Wu, Yuting Liu, Jiale Zhao, Yibei Gui, Hailin Wang, Lijun Wang, Yiyang Luo, Gang Zhou, Yumin He, Chengfu Yuan. Mechanistic Studies on the Antidiabetic Properties of GallotanninsCurrent Pharmaceutical Design 2025; 31(8): 575 doi: 10.2174/0113816128338114241021110221
2
Xiao Yang, Xinghui Li. Research Progress on the Association Between GLP-1 Receptor Agonists and CardiomyopathyReviews in Cardiovascular Medicine 2025; 26(8) doi: 10.31083/RCM37180
3
Ya-Xin Zhu, Wei Zhang, Hui-Lin Qu, Yue Zhang, Ruo-Qian Zhou, Ping Li, Fang Wang, Yan Zhang, Hui-Hui Liu, Sha Li, Qian Dong, Ke-Fei Dou, Yuan-Lin Guo, Jian-Jun Li, Rui-Xia Xu. Liraglutide alleviates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by enhancing mitophagy mediated by the AMPK-Parkin signaling pathwayWorld Journal of Diabetes 2025; 16(12): 112423 doi: 10.4239/wjd.v16.i12.112423
4
Beatrice Polini, Sandra Ghelardoni, Gerarda Capone, Emilia Monti, Grazia Chiellini, Vincenzo Lionetti, Raffaele De Caterina, Rosalinda Madonna. Circulating microRNAs in pulmonary arterial hypertension: biomarkers for diagnosis, prognostic stratification, and treatmentGeroScience 2026;  doi: 10.1007/s11357-026-02095-0